| 1 |
Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, et al. The  guideline for the definition, classification, diagnosis and management of urticaria. Allergy 2018;73:1393-414.
DOI
|
| 2 |
Maurer M, Magerl M, Ansotegui I, Aygoren-Pursun E, Betschel S, Bork K, et al. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update. Allergy 2018;73:1575-96.
DOI
|
| 3 |
Bernstein JA, Cremonesi P, Hoffmann TK, Hollingsworth J. Angioedema in the emergency department: a practical guide to differential diagnosis and management. Int J Emerg Med 2017;10:15.
DOI
|
| 4 |
Jung JW, Suh DI, Park HJ, Kim S, Kwon HS, Yang MS, et al. Clinical features of hereditary angioedema in Korean patients: a nationwide multicenter study. Int Arch Allergy Immunol 2018;176:272-9.
DOI
|
| 5 |
Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med 2006;119:267-74.
DOI
|
| 6 |
Farkas H, Martinez-Saguer I, Bork K, Bowen T, Craig T, Frank M, et al. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency. Allergy 2017;72:300-13.
DOI
|
| 7 |
Shin S, Lee YT, Lee KY, Park J, Lee JH, Yang EA. Complement 4 (C4) levels in 4-year-old girl with angioedema. Clin Exp Pediatr 2020;63:30-1.
DOI
|
| 8 |
Magerl M, Doumoulakis G, Kalkounou I, Weller K, Church MK, Kreuz W, et al. Characterization of prodromal symptoms in a large population of patients with hereditary angio-oedema. Clin Exp Dermatol 2014;39:298-303.
DOI
|
| 9 |
Farkas H, Kohalmi KV. Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years. Expert Rev Clin Immunol 2018;14:447-60.
DOI
|
webmaster
